Filing Details
- Accession Number:
- 0001209191-21-028377
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-04-26 18:10:06
- Reporting Period:
- 2021-04-22
- Accepted Time:
- 2021-04-26 18:10:06
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1322505 | Albireo Pharma Inc. | ALBO | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1572002 | Taylor Patrick Horn | C/O Albireo Pharma, Inc. 10 Post Office Square, Suite 1000 Boston MA 02109 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-04-22 | 90 | $31.75 | 11,893 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Shares sold pursuant to a Rule 10b5-1 arrangement established in October 2019 to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
- Represents 4,205 shares of common stock and 7,688 restricted stock units. Includes 940 shares of common stock acquired under the Albireo Pharma, Inc. 2018 Employee Stock Purchase Plan (the "ESPP") on May 31, 2019, 13 shares of common stock acquired under the ESPP on November 30, 2019, and 1,205 shares of common stock acquired under the ESPP on May 31, 2020.
Billionaire Hedge Funds
